Erratum: Ebola virus replication and disease without immunopathology in mice expressing transgenes to support human myeloid and lymphoid cell engraftment (Journal of Infectious Diseases (2016) 214:S3 (S308-S318) DOI: 10.1093/infdis/jiw248);Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment

Journal of Infectious Diseases

Volumn 214, Issue , 2016, Pages S308-S318

  Spengler, Jessica R ^a   Lavender, Kerry J ^b   Martellaro, Cynthia ^c   Carmody, Aaron ^d   Kurth, Andreas ^g   Keck, James G ^f   Saturday, Greg ^e   Scott, Dana P ^e   Nichol, Stuart T ^a   Hasenkrug, Kim J ^b   Spiropoulou, Christina F ^a   Feldmann, Heinz ^c   Prescott, Joseph ^c  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Laboratory of Persistent Viral Diseases   (United States)

^c Laboratory of Virology   (United States)

^d Laboratory of Virology   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f JACKSON LABORATORY   (United States)

^g ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Ebola; Flow cytometry; Hemorrhagic fever; Humanized NSG SGM3 mice; Immune response; Immunopathology; Myeloid cell; Virus

Indexed keywords

VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CD34 SELECTION; CELL INFILTRATION; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; ENGRAFTMENT; GENE EXPRESSION; GENETIC VARIABILITY; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INOCULATION; LONGITUDINAL STUDY; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VIRUS REPLICATION; ANIMAL; DISEASE MODEL; IMMUNOLOGY; LIVER; LYMPHOCYTE; PATHOLOGY; PHYSIOLOGY; SPLEEN; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; DISEASE MODELS, ANIMAL; EBOLAVIRUS; HEMATOPOIETIC STEM CELLS; HEMORRHAGIC FEVER, EBOLA; HUMANS; LIVER; LYMPHOCYTES; MICE; MICE, TRANSGENIC; MYELOID CELLS; SPLEEN; TRANSGENES; VIRUS REPLICATION;

EID: 84990878211     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix438     Document Type: Erratum

References (35)

1. World Health Organization. Ebola situation report, 2016. http://apps.who.int/ebola/current-situation/ebola-situation-report-17-february-2016. Accessed 18 February 2016.
2. Ströher U, West E, Bugany H, Klenk HD, Schnittler HJ, Feldmann H. Infection and activation of monocytes by Marburg and Ebola viruses. J Virol 2001; 75:11025-33.
3. Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol 1996; 70:2208-14.
4. Bosio CM, Aman MJ, Grogan C, et al. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 2003; 188:1630-8.
5. Hutchinson KL, Rollin PE. Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis 2007; 196 (suppl):S357-63.
6. Jesudason S, Collins MG, Rogers NM, Kireta S, Coates PTH. Non-human primate dendritic cells. J Leukoc Biol 2012; 91:217-28.
7. Magalhaes I, Vudattu NK, Ahmed RK, et al. High content cellular immune profiling reveals differences between rhesus monkeys and men. Immunology 2010; 131:128-40.
8. Barreiro LB, Marioni JC, Blekhman R, Stephens M, Gilad Y. Functional comparison of innate immune signaling pathways in primates. PLoS Genet 2010; 6: e1001249.
9. Waterston RH, Lindblad-Toh K, Birney E, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002; 420:520-62.
10. Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172:2731-8.
11. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 1998; 178:651-61.
12. Shultz LD, Lyons BL, Burzenski LM, et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005; 174:6477-89.
13. Ishikawa F, Yasukawa M, Lyons B, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor ? chain null mice. System 2005; 106:1565-73.
14. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154:180-91.
15. Baskerville A, Bowen ETW, Platt GS, McArdell LB, Simpson DiH. The pathology of experimental Ebola virus infection in monkeys. J Pathol 1978; 125:131-8.
16. Ryabchikova EI, Kolesnikova LV, Netesov SV. Animal pathology of filoviral infections. Curr Top Microbiol Immunol 1999 235:145-73.
17. Ryabchikova EI, Kolesnikova LV, Luchko SV. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J Infect Dis 1999; 179(suppl): S199-202.
18. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003; 163:2347-70.
19. Wunderlich M, Chou F-S, Link KA, et al. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GMCSF and IL-3. Leukemia 2010; 24:1785-8.
20. Billerbeck E, Barry WT, Mu K, Dorner M, Rice CM, Ploss A. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2R{gamma}null humanized mice. Blood 2011; 117:3076-86.
21. Lüdtke A, Oestereich L, Ruibal P, et al. Ebola virus disease in mice transplanted with human hematopoietic stem cells. J Virol 2015; 89:4700-4.
22. Bird BH, Spengler JR, Chakrabarti AK, et al. Humanized mouse model of Ebola virus disease mimics immune responses in human disease. J Infect Dis 2016; 213:703-11.
23. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea-preliminary report. N Engl J Med 2014; 371:1418-25.
24. Hoenen T, Groseth A, Feldmann F, et al. Complete genome sequences of three Ebola virus isolates from the 2014 outbreak in west Africa. Genome Announc 2014; 2:e01331-14.
25. Haddock E, Feldmann F, Feldmann H. Effective chemical inactivation of Ebola virus. Emerg Infect Dis 2016; 22:1292-4.
26. Groseth A, Marzi A, Hoenen T, et al. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog 2012; 8:e1002847.
27. Schnittler HJ, Feldmann H. Molecular pathogenesis of filovirus infections: role of macrophages and endothelial cells. Curr Top Microbiol Immunol 1999; 235:175-204.
28. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol 2015; 235:153-74.
29. Harari D, Abramovich R, Zozulya A, et al. Bridging the species divide: transgenic mice humanized for type-I interferon response. PLoS One 2014; 9:e84259.
30. Gary-Gouy H, Lebon P, Dalloul AH. Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J Interferon Cytokine Res 2002; 22:653-9.
31. Mahanty S, Gupta M, Paragas J, Bray M, Ahmed R, Rollin PE. Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection. Virology 2003; 312:415-24.
32. Bray M. The role of the type I interferon response in the resistance of mice to filovirus infection. J Gen Virol 2001; 82(Pt 6):1365-73.
33. Bray M, Hatfill S, Hensley L, Huggins JW. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J Comp Pathol 2001; 125:243-53.
34. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011; 377:849-62.
35. McElroy AK, Erickson BR, Flietstra TD, et al. Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis 2014; 210:558-66.